When we focused on WR‐DLBCL and LN‐DLBCL, we found no significant differences in MYC, BCL2, and double expression of MYC and BCL2, p53, and CD5 in these two subgroups. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.